Quantum Cyber N.V. Operating Expense
Quantum Cyber N.V. (QUCY) reported Operating Expense of $8.28 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2025-09-26
- Quantum Cyber N.V. operating expense for the quarter ending 2023-12-31 was $6.73M, a 20.18% decline year-over-year.
- Quantum Cyber N.V. operating expense for the quarter ending 2023-09-30 was $5.73M, a 4.25% increase year-over-year.
- Quantum Cyber N.V. operating expense for the quarter ending 2023-06-30 was $8.07M, a 14.88% increase year-over-year.
- Quantum Cyber N.V. operating expense for the quarter ending 2023-03-31 was $6.63M, a 16.71% increase year-over-year.
| Period end | Operating Expense 3 month | Operating Expense 6 month | Operating Expense 6 month as first filed | Operating Expense 9 month | Operating Expense 12 month | Operating Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-06-30 | $8.28M 6-K · filed 2025-09-26 | |||||
| 2024-12-31 | $19.27M 20-F · filed 2025-03-31 | |||||
| 2024-06-30 | $10.13M 6-K · filed 2025-09-26 | |||||
| 2023-12-31 | $6.73M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $12.45M derived: sum of 2 quarters · filed 2025-03-31 | $20.53M derived: sum of 3 quarters · filed 2025-03-31 | $27.15M 20-F · filed 2025-03-31 | ||
| 2023-09-30 | $5.73M 6-K · filed 2023-11-16 | $13.80M derived: sum of 2 quarters · filed 2023-11-16 | $20.43M 6-K · filed 2023-11-16 | $28.85M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-06-30 | $8.07M 6-K · filed 2023-08-15 | $14.70M 6-K · filed 2024-10-18 | $23.13M derived: sum of 3 quarters · filed 2025-03-31 | $28.62M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-03-31 | $6.63M 6-K · filed 2023-05-16 | $15.05M derived: sum of 2 quarters · filed 2025-03-31 | $20.55M derived: sum of 3 quarters · filed 2025-03-31 | $27.57M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2022-12-31 | $8.43M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $13.92M derived: sum of 2 quarters · filed 2025-03-31 | $20.95M derived: sum of 3 quarters · filed 2025-03-31 | $26.63M 20-F · filed 2025-03-31 | $26.69M 20-F · filed 2023-04-07 | |
| 2022-09-30 | $5.49M 6-K · filed 2023-11-16 | $12.52M derived: sum of 2 quarters · filed 2023-11-16 | $18.20M 6-K · filed 2023-11-16 | |||
| 2022-06-30 | $7.03M 6-K · filed 2023-08-15 | $12.71M 6-K · filed 2023-08-15 | $12.70M 6-K · filed 2022-09-07 | |||
| 2022-03-31 | $5.68M 6-K · filed 2023-05-16 | |||||
| 2021-12-31 | $9.90M 20-F · filed 2024-04-09 | |||||
| 2021-06-30 | $607.17K 6-K · filed 2022-09-07 | |||||
| 2020-12-31 | $796.80K 20-F · filed 2023-04-07 | |||||
| 2019-12-31 | $860.64K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |